1. Pharmacokinetic Optimisation in the Treatment of Parkinson’s Disease

   • Dag Nyholm

   Review Article 08 January 2013 Pages: 109 - 136

   

2. Fosamprenavir

   • Mary Beth Wire
   • Mark J. Shelton
   • Scott Studenberg

   Review Article 08 January 2013 Pages: 137 - 168

   

3. Pharmacokinetic Interaction between Levofloxacin and Ciclosporin or Tacrolimus in Kidney Transplant Recipients

   • Stefano Federico
   • Rosa Carrano
   • Vincenzo Basile

   Original Research Article 08 January 2013 Pages: 169 - 175

   

4. Role of Mechanistically-Based Pharmacokinetic/Pharmacodynamic Models in Drug Development

   • Scott Marshall
   • Fiona Macintyre
   • Niclas E. Jonsson

   Original Research Article 08 January 2013 Pages: 177 - 197

   

5. Pharmacokinetics of Darbepoetin Alfa after Intravenous or Subcutaneous Administration in Patients with Non-myeloid Malignancies Undergoing Chemotherapy

   • Anne C. Heatherington
   • Christian Dittrich
   • Johannes Schneller

   Original Research Article 08 January 2013 Pages: 199 - 211

   

6. Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

   • David J. Back
   • Andrew Owen
   • Saye H. Khoo

   Correspondence 08 January 2013 Pages: 213 - 214

7. The Authors’ Reply

   • Alwin D. R. Huitema
   • Jos H. Beijnen

   Correspondence 08 January 2013 Pages: 214 - 215